Literature DB >> 28964445

Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.

Yen Wei Lim1, Asrul Akmal Shafie2, Gin Nie Chua3, Mohammed Azmi Ahmad Hassali2.   

Abstract

BACKGROUND: One major challenge in prioritizing health care using cost-effectiveness (CE) information is when alternatives are more expensive but more effective than existing technology. In such a situation, an external criterion in the form of a CE threshold that reflects the willingness to pay (WTP) per quality-adjusted life-year is necessary.
OBJECTIVES: To determine a CE threshold for health care interventions in Malaysia.
METHODS: A cross-sectional, contingent valuation study was conducted using a stratified multistage cluster random sampling technique in four states in Malaysia. One thousand thirteen respondents were interviewed in person for their socioeconomic background, quality of life, and WTP for a hypothetical scenario.
RESULTS: The CE thresholds established using the nonparametric Turnbull method ranged from MYR12,810 to MYR22,840 (~US $4,000-US $7,000), whereas those estimated with the parametric interval regression model were between MYR19,929 and MYR28,470 (~US $6,200-US $8,900). Key factors that affected the CE thresholds were education level, estimated monthly household income, and the description of health state scenarios.
CONCLUSIONS: These findings suggest that there is no single WTP value for a quality-adjusted life-year. The CE threshold estimated for Malaysia was found to be lower than the threshold value recommended by the World Health Organization.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Malaysia; contingent valuation method; cost-effectiveness threshold; quality-adjusted life-year (QALY); willingness to pay (WTP)

Mesh:

Year:  2017        PMID: 28964445     DOI: 10.1016/j.jval.2017.04.002

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  6 in total

Review 1.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

2.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

3.  Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia.

Authors:  Asrul Akmal Shafie; Chin Hui Ng
Journal:  Clinicoecon Outcomes Res       Date:  2020-06-22

4.  Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.

Authors:  Farhana Aminuddin; Nur Amalina Zaimi; Mohd Shaiful Jefri Mohd Nor Sham Kunusagaran; Mohd Shahri Bahari; Nor Zam Azihan Mohd Hassan
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

5.  Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study.

Authors:  Siti Norain Azahar; Saperi Sulong; Wan Asyraf Wan Zaidi; Norliza Muhammad; Yusof Kamisah; Norliana Masbah
Journal:  Int J Environ Res Public Health       Date:  2022-01-19       Impact factor: 3.390

6.  Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression.

Authors:  Afentoula G Mavrodi; Stavros A Chatzopoulos; Vassilis H Aletras
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.